Reuters logo
BRIEF-Braeburn Pharmaceuticals Inc files for IPO of up to $150 mln - SEC filing
December 30, 2016 / 11:03 PM / a year ago

BRIEF-Braeburn Pharmaceuticals Inc files for IPO of up to $150 mln - SEC filing

Dec 30 (Reuters) - Braeburn Pharmaceuticals Inc

* Braeburn Pharmaceuticals Inc files for IPO of up to $150 million - SEC filing

* Braeburn Pharmaceuticals Inc - J.P. Morgan, BofA Merrill Lynch, Deutsche Bank securities are underwriters to IPO

* Braeburn Pharmaceuticals Inc - Apple Tree Partners IV LP to buy $40 million of common stock in private placement concurrent with completion of IPO

* Braeburn Pharmaceuticals Inc - following the IPO, Apple Tree Partners IV, L.P. and its affiliates will control a majority of the voting power of co’s common stock

* Braeburn Pharmaceuticals Inc - plans to apply to list common stock on the Nasdaq Global Market under the symbol “BBRX”

* Braeburn Pharmaceuticals Inc - IPO size estimated solely for the purpose of calculating the registration fee Source text: (bit.ly/2hDfLhV)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below